Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin-A2 is an essential regulator at multiple checkpoints within the mammalian somatic cell cycle. By activating specific kinases at precise times, it ensures orderly progression through DNA synthesis into mitosis while also playing emerging roles outside canonical cell division—including modulation of cellular architecture relevant for invasion/metastasis. Its dysregulation marks potential oncogenic transformation points across diverse cancer types.
CDK1/CDK2 activator; promotes cell cycle progression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-A2 (CycA2).